Alternatively, both malignancies possibly evolved from a common precursor defined by a predisposition mutation with divergent evolution into MPN through acquisition of the <i>JAK2</i> V617F and AML through acquisition of different mutations. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.